{"disease":{"id":"congestive-heart-failure-chf","name":"congestive heart failure chf"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02983812","title":"Developing Enhanced Prediction Models","phase":"","overall_status":"COMPLETED","enrollment_count":500,"lead_sponsor_name":"University of Pennsylvania","has_results":false},{"nct_id":"NCT06993220","title":"Evaluating Residual Congestion at Discharge in Acute Heart Failure Patients","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Consorci Sanitari Integral","has_results":false},{"nct_id":"NCT06628973","title":"Social Prescribing to Improve Adherence and Outcomes in Women With Heart Failure","phase":"NA","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"McGill University Health Centre/Research Institute of the McGill University Health Centre","has_results":false},{"nct_id":"NCT03102437","title":"Continued Access Protocol for the Evaluation of the OPTIMIZER Smart System","phase":"NA","overall_status":"TERMINATED","enrollment_count":106,"lead_sponsor_name":"Impulse Dynamics","has_results":true},{"nct_id":"NCT06683053","title":"Evaluation of the Use of Empagliflozin in Patients with HF with PEF in a Cardiology Outpatient Department","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":90,"lead_sponsor_name":"Conrado Roberto Hoffmann Filho","has_results":false},{"nct_id":"NCT03255226","title":"Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics Study of Tolvaptan in Pediatric Congestive Heart Failure (CHF) Patients With Volume Overload","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Otsuka Pharmaceutical Co., Ltd.","has_results":true},{"nct_id":"NCT03339310","title":"Evaluation of the Safety and Efficacy of the 2-lead OPTIMIZER® Smart System","phase":"NA","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Impulse Dynamics","has_results":false}],"total":7},"guidelines":[],"source":"Drug Landscape verified database"}